Physician profile
Krishnan Ramani
NPI 1518937630
$1,388.17
in general payments reported to CMS, 2019-2025
18 companies · $23.55 in 2025
The $23.55 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $133 · 2021: $192 · 2022: $269 · 2023: $41.20 · 2024: $114 · 2025: $23.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $231.89 | 2019-2022 | |
| Amgen INC. | $213.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $208.99 | 2019-2022 | |
| Abbott Laboratories | $149.90 | 2019-2025 | Xience Skypoint |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.16 | 2019-2022 | |
| Boston Scientific Corporation | $99.04 | 2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $82.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $80.50 | 2019-2022 | |
| Amarin Pharma, INC. | $46.01 | 2021-2022 | |
| Heartflow, INC. | $29.46 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $28.80 | 2019 | |
| Daiichi Sankyo INC. | $24.62 | 2023 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $17.19 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.69 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.58 | 2023 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.67 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishnan Ramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.